Cue Biopharma, Inc.
Methods for modulating an immune response
Last updated:
Abstract:
The present disclosure provides methods of modulating an immune response in an individual. The present disclosure provides methods of treatment. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) and an immune checkpoint inhibitor to an individual. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) to an individual who is undergoing treatment with immune checkpoint inhibitor.
Status:
Grant
Type:
Utility
Filling date:
19 Feb 2021
Issue date:
31 Aug 2021